Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes

Hammarlund, 2003, Duration of antiviral immunity after smallpox vaccination, Nat. Med., 9, 1131, 10.1038/nm917 Burton, 2012, A blueprint for HIV vaccine discovery, Cell Host Microbe, 12, 396, 10.1016/j.chom.2012.09.008 Yong, 2019, Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus, Front. Microbiol., 10, 1781, 10.3389/fmicb.2019.01781 WHO, https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19–13-april-2021, 2020. Zhang, 2020, Sensitive, rapid, low-cost, and multiplexed COVID-19 monitoring by the wireless telemedicine platform, Matter, 3, 1818, 10.1016/j.matt.2020.11.001 Day, 2020, Covid-19: four fifths of cases are asymptomatic, China figures indicate, BMJ, 369, 1375, 10.1136/bmj.m1375 Shin, 2020, COVID-19 vaccine development and a potential nanomaterial path forward, Nat. Nanotechnol., 15, 646, 10.1038/s41565-020-0737-y Zhou, 2020, Engineering antiviral vaccines, ACS Nano, 14, 12370, 10.1021/acsnano.0c06109 Bull, 2015, Evolutionary reversion of live viral vaccines: can genetic engineering subdue it?, Virus Evol., 1, vev005, 10.1093/ve/vev005 Coffman, 2010, Vaccine adjuvants: putting innate immunity to work, Immunity, 33, 492, 10.1016/j.immuni.2010.10.002 Barouch, 2004, Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity, J. Immunol., 172, 6290, 10.4049/jimmunol.172.10.6290 Amoscato, 1998, Rapid extracellular degradation of synthetic class I peptides by human dendritic cells, J. Immunol., 161, 4023, 10.4049/jimmunol.161.8.4023 Pietroiusti, 2013, Interactions of engineered nanoparticles with organs protected by internal biological barriers, Small, 9, 1557, 10.1002/smll.201201463 Smith, 2013, Applications of nanotechnology for immunology, Nat. Rev. Immunol., 13, 592, 10.1038/nri3488 Goldberg, 2019, Improving cancer immunotherapy through nanotechnology, Nat. Rev. Cancer, 19, 587, 10.1038/s41568-019-0186-9 Chauhan, 2020, Nanotechnology for COVID-19: therapeutics and Vaccine Research, ACS Nano, 14, 7760, 10.1021/acsnano.0c04006 Chung, 2020, COVID-19 vaccine frontrunners and their nanotechnology design, ACS Nano, 14, 12522, 10.1021/acsnano.0c07197 Lung, 2020, Nanoparticle formulated vaccines: opportunities and challenges, Nanoscale, 12, 5746, 10.1039/C9NR08958F Bohnsack Jf Fau - Brown, 1986, The role of the spleen in resistance to infection, Annu. Rev. Med., 37, 49, 10.1146/annurev.me.37.020186.000405 Batista, 2009, The who, how and where of antigen presentation to B cells, Nat. Rev. Immunol., 9, 15, 10.1038/nri2454 Klei, 2017, From the cradle to the grave: the role of macrophages in erythropoiesis and erythrophagocytosis, Front. Immunol., 8, 73, 10.3389/fimmu.2017.00073 Minasyan, 2016, Mechanisms and pathways for the clearance of bacteria from blood circulation in health and disease, Pathophysiology, 23, 61, 10.1016/j.pathophys.2016.03.001 Minasyan, 2018, Phagocytosis and oxycytosis: two arms of human innate immunity, Immunol. Res., 66, 271, 10.1007/s12026-018-8988-5 de Back, 2014, Of macrophages and red blood cells; a complex love story, Front. Physiol., 5, 9, 10.3389/fphys.2014.00009 Brenner, 2018, Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude, Nat. Commun., 9, 2684, 10.1038/s41467-018-05079-7 Danielyan, 2008, Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator, Circulation, 118, 1442, 10.1161/CIRCULATIONAHA.107.750257 Pishesha, 2017, Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease, Proc. Natl. Acad. Sci. USA, 114, 3157, 10.1073/pnas.1701746114 Ukidve, 2020, Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function, Proc. Natl. Acad. Sci. USA, 117, 17727, 10.1073/pnas.2002880117 Daniel Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 Renhong Yan, 2020, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, 367, 1444, 10.1126/science.abb2762 Benvenuto, 2020, The 2019-new coronavirus epidemic: evidence for virus evolution, J. Med. Virol., 92, 455, 10.1002/jmv.25688 Prompetchara, 2020, Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic, Asian Pac. J. Allergy Immunol., 38, 1 Zhou, 2015, Immune effects of R848: evidences that suggest an essential role of TLR7/8-induced, Myd88- and NF-κB-dependent signaling in the antiviral immunity of Japanese flounder (Paralichthys olivaceus), Dev. Comp. Immunol., 49, 113, 10.1016/j.dci.2014.11.018 McCartney, 2009, Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells, J. Exp. Med., 206, 2967, 10.1084/jem.20091181 Moody, 2014, Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques, J. Virol., 88, 3329, 10.1128/JVI.03309-13 Florindo, 2020, Immune-mediated approaches against COVID-19, Nat. Nanotechnol., 15, 630, 10.1038/s41565-020-0732-3 Wang, 2019, Polydopamine as the antigen delivery nanocarrier for enhanced immune response in tumor immunotherapy, ACS Biomater. Sci. Eng., 5, 2330, 10.1021/acsbiomaterials.9b00359 Ye, 2011, Bioinspired catecholic chemistry for surface modification, Chem. Soc. Rev., 40, 4244, 10.1039/c1cs15026j Pan, 2016, The effect of polymeric nanoparticles on biocompatibility of carrier red blood cells, PLOS One, 11 Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Guermonprez, 2002, Antigen presentation and T cell stimulation by dendritic cells, Annu. Rev. Immunol., 20, 621, 10.1146/annurev.immunol.20.100301.064828 Savina, 2007, Phagocytosis and antigen presentation in dendritic cells, Immunol. Rev., 219, 143, 10.1111/j.1600-065X.2007.00552.x Liu, 2016, Pathogen-mimicking polymeric nanoparticles based on dopamine polymerization as vaccines adjuvants induce robust humoral and cellular immune responses, Small, 12, 1744, 10.1002/smll.201503662 Borriello, 1997, B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation, Immunity, 6, 303, 10.1016/S1074-7613(00)80333-7 Matundan H, 2019, Herpes simplex virus 1 ICP22 suppresses CD80 expression by murine dendritic cells, J. Virol., 93, 1803, 10.1128/JVI.01803-18 Wen, 2019, Adipocytes as anticancer drug delivery depot, Matter, 1, 1203, 10.1016/j.matt.2019.08.007 Weeratna, 2000, CpG DNA induces stronger immune responses with less toxicity than other adjuvants, Vaccine, 18, 1755, 10.1016/S0264-410X(99)00526-5 Thomsen, 2004, Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery, Vaccine, 22, 1799, 10.1016/j.vaccine.2003.09.052 Shishido, 2012, Humoral innate immune response and disease, Clin. Immunol., 144, 142, 10.1016/j.clim.2012.06.002 Zimmermann, 2019, Antigen extraction and B cell activation enable identification of rare membrane antigen specific human B cells, Front. Immunol., 10, 829, 10.3389/fimmu.2019.00829 Stebegg, 2018, Regulation of the germinal center response, Front. Immunol., 9, 2469, 10.3389/fimmu.2018.02469 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 382, 1708, 10.1056/NEJMoa2002032 Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nat. Rev. Immunol., 20, 363, 10.1038/s41577-020-0311-8 Chesler, 2002, The role of IFN-gamma in immune responses to viral infections of the central nervous system, Cytokine Growth Factor Rev., 13, 441, 10.1016/S1359-6101(02)00044-8 Mancuso, 2007, Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria, J. Immunol., 178, 3126, 10.4049/jimmunol.178.5.3126 Samuel, 2001, Antiviral actions of interferons, Clin. Microbiol. Rev., 14, 778, 10.1128/CMR.14.4.778-809.2001 Haji Abdolvahab, 2021, Potential role of interferons in treating COVID-19 patients, Int. Immunopharmacol., 90, 10.1016/j.intimp.2020.107171 Hu, 2012, Erythrocyte-inspired delivery systems, Adv. Healthc. Mater., 1, 537, 10.1002/adhm.201200138 Yang, 2012, Polydopamine-mediated surface modification of scaffold materials for human neural stem cell engineering, Biomaterials, 33, 6952, 10.1016/j.biomaterials.2012.06.067